Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 148
Filter
1.
Eur J Clin Microbiol Infect Dis ; 41(11): 1295-1304, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36114431

ABSTRACT

To establish a biological profile and disease aetiologies for one of four burials recovered during a Time Team dig at the St. Mary Magdalen leprosarium, Winchester, UK in AD 2000. Osteological techniques were applied to estimate age at death, biological sex, stature and pathology. Visual assessment of the material was supplemented by radiographic examination. Evidence for leprosy DNA was sought using ancient DNA (aDNA) analysis. The remains are those of a male individual excavated from a west-east aligned grave. The skeleton shows signs of two pathologies. Remodelling of the rhino-maxillary area and degenerative changes to small bones of the feet and reactive bone on the distal lower limbs suggest a multibacillary form of leprosy, whereas the right tibia and fibula show the presence of a primary neoplasm identified as an osteosarcoma. The aDNA study confirmed presence of Mycobacterium leprae in several skeletal elements, and the strain was genotyped to the 3I lineage, one of two main SNP types present in mediaeval Britain and ancestral to extant strains in America. This is a rare documentation of leprosy in association with a primary neoplasm.


Subject(s)
Leprosy, Lepromatous , Leprosy , Osteosarcoma , Bone and Bones , DNA, Ancient , Humans , Leprosy/diagnosis , Leprosy, Lepromatous/microbiology , Male , Mycobacterium leprae/genetics , Osteosarcoma/genetics , United Kingdom
2.
Microbiol Resour Announc ; 11(7): e0010322, 2022 Jul 21.
Article in English | MEDLINE | ID: mdl-35758721

ABSTRACT

The complete genome sequence of Paraclostridium bifermentans was obtained by assembly of Illumina and Oxford Nanopore (ONT) reads. The sequence will enable study into the organism's ability to biohydrogenate unsaturated acyl chains in the transformation of C20 polyunsaturated fatty acids (PUFAs) into the corresponding bioactive non-methylene-interrupted fatty acids (NMIFAs).

3.
Tuberculosis (Edinb) ; 128: 102088, 2021 05.
Article in English | MEDLINE | ID: mdl-34022508

ABSTRACT

BACKGROUND: The remains of a 3-5 year-old child from the late mediaeval cemetery serving the Priory of St. Peter and St. Paul, Taunton, Somerset, UK was the subject of an aDNA study. OBJECTIVE: The aim was to distinguish between two differential diagnoses suggested by earlier osteological examination of the remains; either tuberculosis or Langerhans cell histiocytosis. FINDINGS: The remains tested positive for MTB complex markers, corroborating this diagnosis reached on osteological grounds. Based on positivity for the mtp40 element and a deletion in the pks15/1 locus, we conclude that infection was due to a strain of the human pathogen M.tuberculosis belonging to lineage 4. Although DNA recovered from the case was heavily fragmented, sex determination by amelogenin PCR suggested these are the remains of a young male child. The findings are discussed considering additions to the literature since the original report. CONCLUSIONS: Descriptions of tuberculosis in children from this period are rare and burial Sk2077 represents the first UK example of a pre-adolescent individual to have a molecular diagnosis combined with osteological pathology. This provides an important reference of childhood tuberculosis and insight into the likely presence of tuberculosis in the mediaeval adult population served by this cemetery.


Subject(s)
Tuberculosis/history , Cadaver , Cemeteries , Child, Preschool , England , History, Medieval , Humans , Male , Mycobacterium tuberculosis/genetics , Tuberculosis/epidemiology
4.
Blood Cancer J ; 2(7): e80, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22852049

ABSTRACT

We previously reported that children in the UKALL XI ALL trial with HLA-DP 1 and -DP 3 supertypes had significantly worse event-free survival (EFS) than children with other DP supertypes. As DP 1 and DP 3 share two of four key antigen-binding amino-acid polymorphisms (aspartic acid84-lysine69), we asked whether Asp84-Lys69 or Asp84 alone were independent prognostic indicators in childhood acute lymphoblastic leukemia (ALL). We analysed EFS in 798 UKALL XI patients, stratified by Asp84-Lys69 vs non-Asp84-Lys69, for a median follow-up of 12.5 years. Asp84-Lys69 was associated with a significantly worse EFS than non-Asp84-Lys69 (5-year EFS: Asp84-Lys69: 58.8% (95% CI (confidence of interval): 52.7-64.9%); non-Asp84-Lys69: 67.3% (63.4-71.2%); 2P=0.007). Post-relapse EFS was 10% less in Asp84-Lys69 than non-Asp84-Lys69 patients. EFS was significantly worse (P=0.03) and post-relapse EFS marginally worse (P=0.06) in patients with Asp84 compared with Gly84. These results suggest that Asp84-Lys69 predicted adverse EFS in the context of UKALL XI because of Asp84, and may have influenced post-relapse EFS. We speculate that this may be due to the recruitment of Asp84-Lys69-restricted regulatory T cells in the context of this regimen, leading to the re-emergence of residual disease. However, functional and molecular studies of the prognostic value of this and other HLA molecular signatures in other childhood ALL trials are needed.

5.
Leukemia ; 23(5): 863-9, 2009 May.
Article in English | MEDLINE | ID: mdl-19148140

ABSTRACT

We previously reported that susceptibility to childhood B cell precursor ALL (BCP ALL) is associated with HLA-DPB1 alleles having glutamic acid (E) rather than lysine (K) in the P4 antigenic peptide-binding pocket. Clustering approximately 90% of DPB1 alleles into DPB69E (DP2, 6, 8) and DPB69K (DP1, 3, 4) supertypes revealed that DP2 and DP8 are associated with BCP ALL, but DP6 is also associated with non-BCP leukaemia. Here, we report that only one of seven alleles with the DP6 supertype (DPB1(*)0601) is associated with childhood leukaemia (leukaemia vs controls: odds ratio, 95% confidence interval [OR, CI]: 4.6, 2.0-10.4; corrected P=0.019), but not with childhood solid tumours or lymphomas. DPB1(*)0601 is also significantly associated with leukaemia subtypes, including BCP ALL, Pro-B ALL, T-ALL and AML. DPB1(*)0601 is significantly over-transmitted (76.9%) from parents to children with BCP ALL (OR; CI: 4.7; 1.01-22.2). Sequencing the coding region of DPB1(*)0601 revealed an exon 1-4 haplotype [T-DEAV-KIL-RVI] shared with DPB1(*)0301 and 0901, but no evidence of germline mutations in childhood leukaemia. These results suggest that the DPbeta0601 molecule may be functionally involved in childhood leukaemia. Analysis of peptide binding and T-cell activation by DPbeta0601-peptide complexes should help determine its role in childhood leukaemia causation.


Subject(s)
HLA-DP Antigens/genetics , Haplotypes/genetics , Leukemia, Myeloid, Acute/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Alleles , Amino Acid Sequence , Case-Control Studies , Child , Disease Susceptibility , HLA-DP Antigens/metabolism , HLA-DP beta-Chains , Humans , Infant, Newborn , Leukemia, Myeloid, Acute/metabolism , Molecular Sequence Data , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Sequence Homology, Amino Acid
6.
Br J Cancer ; 98(6): 1125-31, 2008 Mar 25.
Article in English | MEDLINE | ID: mdl-18334973

ABSTRACT

Childhood B-cell precursor (BCP) ALL is thought to be caused by a delayed immune response to an unidentified postnatal infection. An association between BCP ALL and HLA class II (DR, DQ, DP) alleles could provide further clues to the identity of the infection, since HLA molecules exhibit allotype-restricted binding of infection-derived antigenic peptides. We clustered >30 HLA-DPB1 alleles into six predicted peptide-binding supertypes (DP1, 2, 3, 4, 6, and 8), based on amino acid di-morphisms at positions 11 (G/L), 69 (E/K), and 84 (G/D) of the DPbeta(1) domain. We found that the DPbeta11-69-84 supertype GEG (DP2), was 70% more frequent in BCP ALL (n=687; P<10(-4)), and 98% more frequent in cases diagnosed between 3 and 6 years (P<10(-4)), but not <3 or >6 years, than in controls. Only one of 21 possible DPB1 supergenotypes, GEG/GKG (DP2/DP4) was significantly more frequent in BCP ALL (P=0.00004) than controls. These results suggest that susceptibility to BCP ALL is associated with the DP2 supertype, which is predicted to bind peptides with positively charged, nonpolar aromatic residues at the P4 position, and hydrophobic residues at the P1 and P6 positions. Studies of peptide binding by DP2 alleles could help to identify infection(s) carrying these peptides.


Subject(s)
Genetic Predisposition to Disease , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Case-Control Studies , Child , Child, Preschool , Female , Gene Frequency , Genotype , HLA-DP Antigens , HLA-DP beta-Chains , Humans , Infant, Newborn , Male
7.
Br J Cancer ; 96(8): 1265-71, 2007 Apr 23.
Article in English | MEDLINE | ID: mdl-17387343

ABSTRACT

Gardner and co-workers advanced the hypothesis that the Seascale leukaemia cluster could have been caused by new mutations in germ cells, induced by paternal preconceptional irradiation (PPI) exposure at the Sellafield nuclear installation. Since evidence has shown that PPI can increase the de novo germline mutation rate in hypervariable minisatellite loci, we investigated the hypothesis that sporadic childhood leukaemia might be associated with an increased parental germline minisatellite mutation rate. To test this hypothesis, we compared de novo germline mutation rates in the hypervariable minisatellite locus, CEB1, in family trios (both parents and their child) of children with leukaemia (n=135) compared with unaffected control families (n=124). The majority of case and control germline mutations were paternal (94%); the mean paternal germline mutation rates of children with leukaemia (0.083) and control children (0.156) were not significantly different (odds ratio, 95% confidence interval: 0.50, 0.23-1.08; P=0.11). There were no significant differences in case and control parental allele sizes, case and control germline mutation progenitor allele sizes (2.74 vs 2.54 kb; P=0.56), case and control mutant allele sizes (2.71 vs 2.67 kb; P=0.90), mutant allele size changes (0.13 vs 0.26 kb; P=0.10), or mutational spectra. Within the limitation of the number of families available for study, we conclude that childhood leukaemia is unlikely to be associated with increased germline minisatellite instability.


Subject(s)
Germ-Line Mutation , Intracellular Signaling Peptides and Proteins/genetics , Leukemia/genetics , Minisatellite Repeats , Parents , Adolescent , Adult , Case-Control Studies , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Infant , Male
8.
Int J Cancer ; 121(2): 442-7, 2007 Jul 15.
Article in English | MEDLINE | ID: mdl-17390376

ABSTRACT

A proportion of Hodgkin lymphoma (HL) cases are causally associated with the Epstein-Barr virus (EBV) but the aetiology of the remaining cases remains obscure. Over the last 3 decades several studies have found an association between HL and measles virus (MV) including a recent cohort study describing the detection of MV antigens in Hodgkin and Reed-Sternberg cells, the tumour cells in HL. In the present study we looked at the relationship between history of MV infection and risk of developing HL in a population-based, case/control study of HL. In addition we used immunohistochemistry and RT-PCR to look for direct evidence of MV in HL biopsies. There was no significant difference in the proportion of cases reporting previous measles compared to controls in the entire data set or when young adults were considered separately. Using a robust immunohistochemical assay for MV infection, we failed to find evidence of MV in biopsies from 97 cases of HL and RT-PCR studies similarly gave negative results. This study therefore provides no evidence that MV is directly involved in the development of HL. However, when age at first reported MV infection was investigated, significant differences emerged with children infected before school-age having higher risk, especially of EBV-ve HL, when compared with children infected at older ages; the interpretation of these latter results is unclear.


Subject(s)
Hodgkin Disease/virology , Measles virus/growth & development , Measles/virology , Adolescent , Adult , Animals , Case-Control Studies , Cell Line, Tumor , Chlorocebus aethiops , Female , Hodgkin Disease/complications , Hodgkin Disease/pathology , Humans , Immunohistochemistry , Lymph Nodes/pathology , Lymph Nodes/virology , Male , Measles/complications , Measles virus/genetics , Measles virus/metabolism , Middle Aged , Odds Ratio , RNA, Viral/genetics , RNA, Viral/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Vero Cells , Viral Proteins/metabolism
9.
Cancer Genet Cytogenet ; 164(2): 164-7, 2006 Jan 15.
Article in English | MEDLINE | ID: mdl-16434323

ABSTRACT

The ability of topoisomerase 2 inhibitors to induce DNA breakage is well recognized. Previous studies, however, have concentrated on the effects on individual genes. The effects of etoposide on the MLL, RUNX1, and MLLT3 genes were simultaneously studied in the same hemopoietic cell population. We found MLL to be more susceptible to etoposide-induced cleavage than RUNX1 and MLLT3, with maximum cleavage at a lower drug concentration. A higher level of MLL than other gene cleavage was also detected after cellular exposure to all drug concentrations. Greater susceptibility to topoisomerase 2 inhibitor-induced cleavage may explain the more frequent involvement of MLL in treatment-related leukemogenesis.


Subject(s)
Etoposide/toxicity , Myeloid-Lymphoid Leukemia Protein/drug effects , Myeloid-Lymphoid Leukemia Protein/genetics , Core Binding Factor Alpha 2 Subunit/drug effects , Core Binding Factor Alpha 2 Subunit/genetics , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/toxicity , Etoposide/pharmacology , Humans , Leukemia, Myeloid/genetics , Leukemia, Myeloid/pathology , Mutagenicity Tests , Nuclear Proteins/drug effects , Nuclear Proteins/genetics , Topoisomerase II Inhibitors , Tumor Cells, Cultured
10.
Br J Haematol ; 128(4): 493-5, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15686457

ABSTRACT

A single nucleotide polymorphism (SNP) is present at position -174 of the human interleukin-6 gene. The risk of developing Hodgkin's lymphoma (HL) in young adults decreases with an increasing number of C alleles at this position. We analysed the effect of this SNP on incidence and outcome in HL. DNA samples from 408 cases and 349 controls were screened and analysed following stratification by age, histological subtype and Epstein-Barr virus status. Although the risk of classical HL in young adults decreased with increasing C alleles, case-control differences were not significant. An excess of G alleles was observed for nodular lymphocyte predominant HL in young adults (n = 21), which was significant.


Subject(s)
Hodgkin Disease/genetics , Interleukin-6/genetics , Polymorphism, Single Nucleotide , Promoter Regions, Genetic/genetics , Adolescent , Adult , Age Factors , Case-Control Studies , DNA, Neoplasm/genetics , Epstein-Barr Virus Infections/complications , Female , Genotype , Hodgkin Disease/virology , Humans , Male , Middle Aged , Prognosis
11.
Leukemia ; 19(2): 253-9, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15592432

ABSTRACT

The molecular effects of etoposide in haemopoietic cells suggest that mixed lineage leukaemia (MLL) abnormalities can be biomarkers of patient susceptibility to the genotoxic effects of topoisomerase 2 (topo 2) inhibitors. We have prospectively studied treatment-related MLL cleavage and rearrangement in serial samples from 71 children receiving chemotherapy, using Southern blot analysis and panhandle PCR. The results were related to patient demographics, treatment details and outcome. MLL cleavage was identified in six bone marrow samples from five patients 2-10 months after the start of therapy. There was no obvious relationship between the degree of MLL cleavage and cumulative dose or schedule of topo 2 inhibitors. Three children with low percentage (23-30%) cleavage remained well and two were still receiving treatment at study completion. One child with two consecutively positive samples and higher level of MLL cleavage (45-48%) died from treatment-related toxicities and relapsed leukaemia. A patient with haemophagocytic lymphohistiocytosis developed the highest level of MLL cleavage (50%) at 3 months and a treatment-related leukaemia with MLL rearrangement 6 months after the start of treatment. It would appear that some patients are inherently more susceptible to the genotoxic effect of topo 2 inhibitors. The degree and persistence of MLL cleavage may identify patients at risk.


Subject(s)
DNA Topoisomerases, Type II/metabolism , DNA-Binding Proteins/genetics , Enzyme Inhibitors/therapeutic use , Leukemia/drug therapy , Leukemia/genetics , Proto-Oncogenes/genetics , Transcription Factors/genetics , Adolescent , Child , Child, Preschool , DNA-Binding Proteins/drug effects , Gene Rearrangement , Histone-Lysine N-Methyltransferase , Humans , Infant , Mutation/genetics , Myeloid-Lymphoid Leukemia Protein , Proto-Oncogenes/drug effects , Racial Groups , Transcription Factors/drug effects , Treatment Outcome
12.
Br J Cancer ; 91(12): 1990-2, 2004 Dec 13.
Article in English | MEDLINE | ID: mdl-15570305

ABSTRACT

Treatment-related acute myeloid leukaemia (t-AML) is a serious complication of topoisomerase 2 inhibitor therapy and is characterised by the presence of mixed lineage leukaemia (MLL) rearrangement. By molecular tracking, we were able to show that MLL cleavage preceded gene rearrangement by 3 months and before the clinical diagnosis of t-AML in a patient with haemophagocytic lymphohistiocytosis. This is the first report on the sequential detection of the two biomarkers in treatment-related leukaemogenesis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , DNA-Binding Proteins/genetics , Histiocytosis, Non-Langerhans-Cell/drug therapy , Leukemia, Myelomonocytic, Acute/etiology , Neoplasms, Second Primary/genetics , Nucleic Acid Synthesis Inhibitors/adverse effects , Proto-Oncogenes/genetics , Transcription Factors/genetics , Blotting, Southern , Dexamethasone/administration & dosage , Epstein-Barr Virus Infections/complications , Etoposide/adverse effects , Gene Rearrangement , Histiocytosis, Non-Langerhans-Cell/etiology , Histone-Lysine N-Methyltransferase , Humans , Infant , Male , Methotrexate/administration & dosage , Myeloid-Lymphoid Leukemia Protein , Polymerase Chain Reaction , Time Factors , Topoisomerase II Inhibitors
13.
J Clin Pathol ; 56(11): 811-6, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14600123

ABSTRACT

AIMS: The epidemiological and pathological features of Hodgkin lymphoma (HL) are complex. The Epstein-Barr virus (EBV) is consistently associated with a proportion of cases, and these cases are thought to represent a distinct aetiological subgroup of HL. The aim of the present analysis was to determine the age and sex specific incidence of EBV associated and non-associated HL, analysed separately, using data derived from a population based study-the Scotland and Newcastle epidemiological study of Hodgkin's disease (SNEHD). This study also provided a unique opportunity to evaluate accuracy in the current diagnosis and classification of HL. METHODS: SNEHD analysed consecutive cases of HL diagnosed in the study area between 1993 and 1997. Diagnostic biopsy material was retrieved, EBV status of tumours was determined, and histological review was performed. RESULTS: In total, 622 cases were eligible for the study, and EBV studies and histopathological review were performed on biopsy material from 537 and 549 cases, respectively. Accuracy in the overall diagnosis of HL and classification of nodular sclerosis HL was good, but diagnosis of HL in the elderly and classification of other subtypes was less reliable. One third of classic HL cases were EBV associated, and age specific incidence curves for EBV associated and non-associated cases were distinct. CONCLUSIONS: Comparison of age specific incidence curves for EBV associated and non-associated HL supports the hypothesis that these are two distinct aetiological entities. Accuracy in the diagnosis of HL is generally good, but certain subgroups of cases continue to present diagnostic difficulties.


Subject(s)
Epstein-Barr Virus Infections/complications , Hodgkin Disease/virology , Adolescent , Adult , Age Distribution , Aged , Biopsy , Case-Control Studies , England/epidemiology , Epstein-Barr Virus Infections/epidemiology , Female , Hodgkin Disease/epidemiology , Hodgkin Disease/pathology , Humans , Incidence , Male , Middle Aged , Scotland/epidemiology
14.
J Clin Pathol ; 56(11): 873-5, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14600138

ABSTRACT

AIMS: To investigate the association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia. METHODS: Cerebrospinal fluid (CSF) samples from patients with acute myelogenous leukaemia (AML) at diagnosis (n = 2) and acute lymphoblastic leukaemia (ALL) at diagnosis (n = 14) were analysed for parvovirus B19 DNA by means of nested polymerase chain reaction. In addition, samples from patients with benign intracranial hypertension (BIH) (n = 10) and hydrocephalus (n = 13) were tested as controls. RESULTS: Four leukaemia cases were positive-common ALL (n = 2), null cell ALL (n =1), and M7 AML (n = 1)-whereas all controls were negative (Yates corrected chi(2) value, 3.97; p = 0.046; odds ratio, 16.92; confidence interval, 1.03 to 77.18). All four patients were significantly anaemic, but none was encephalitic or had evidence of central nervous system leukaemia. In three of these patients, serum tumour necrosis alpha, interferon gamma, interleukin 6, granulocyte-macrophage colony stimulating factor (range, 34.93-3800.06 pg/ml), and macrophage chemoattractant protein 1 were detectable. All of these four patients carried at least one of the HLA-DRB1 alleles, which have been associated with symptomatic parvovirus B19 infection. CONCLUSION: Erythroid suppression and immune cell proliferation are both associated with B19 infection and may also be important in the pathogenesis of acute leukaemia.


Subject(s)
Leukemia, Megakaryoblastic, Acute/virology , Parvoviridae Infections/complications , Parvovirus B19, Human , Precursor Cell Lymphoblastic Leukemia-Lymphoma/virology , Acute Disease , Child , Child, Preschool , Cytokines/blood , DNA, Viral/cerebrospinal fluid , Female , Humans , Infant , Male , Parvoviridae Infections/immunology
15.
Microbiology (Reading) ; 149(Pt 11): 3213-3220, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14600233

ABSTRACT

Using molecular methods the authors have studied mycobacterial DNA taken from a 19th century victim of tuberculosis. This was the case from which Robert Koch first isolated and cultured the organism responsible for tuberculosis. The mycobacteria were preserved within five glass culture tubes as abundant bacterial colonies on slopes of a gelatinous culture medium of unknown composition. Originally presented by Koch to surgical laryngologist Walter Jobson Horne in London in 1901, the relic has, since 1983, been in the care of the Royal College of Surgeons of England. Light and electron microscopy established the presence of acid-fast mycobacteria but showed that morphological preservation was generally poor. Eleven different genomic loci were successfully amplified by PCR. This series of experiments confirmed that the organisms were indeed Mycobacterium tuberculosis and further showed that the original strain was in evolutionary terms similar to 'modern' isolates, having undergone the TB D1 deletion. Attempts to determine the genotypic group of the isolate were only partially successful, due in part to the degraded nature of the DNA and possibly also to a truncation in the katG gene, which formed part of the classification scheme. Spoligotyping resulted in amplification of DR spacers consistent with M. tuberculosis but with discrepancies between independent extracts, stressing the limitations of this typing method when applied to poorly preserved material.


Subject(s)
Bacteriology/history , Mycobacterium tuberculosis/genetics , Bacteriology/trends , Base Sequence , DNA Primers , DNA, Bacterial/isolation & purification , History, 19th Century , History, 20th Century , Humans , Mycobacterium tuberculosis/ultrastructure , Polymerase Chain Reaction/methods , Tuberculosis/history
16.
Arch Dis Child Fetal Neonatal Ed ; 88(3): F237-44, 2003 May.
Article in English | MEDLINE | ID: mdl-12719399

ABSTRACT

BACKGROUND: Childhood leukaemias express novel, clonotypic fusion genes that may already be present at birth before the clinical manifestation of leukaemia. Exposure of the fetus to diagnostic x rays is reported to increase the risk of childhood leukaemia, and may do so by generating leukaemic fusion genes. Advances in neonatal medicine in the past decade that have extended the limits of viability of preterm babies down to 23 weeks of gestation have resulted in the increased use of diagnostic x rays to monitor neonatal progress. AIM: To investigate whether exposure of very preterm infants to diagnostic x rays in the neonatal period leads to the development of leukaemic fusion genes. METHODS: Peripheral blood samples were collected at birth from very preterm infants (23-30 weeks gestation) and following exposure to diagnostic x rays at intervals of two weeks, until discharge. Cord blood samples from normal full term infants served as controls. Total RNA was extracted from the blood and the expression of the fusion genes TEL-AML1, MLL-AF4, and BCR-ABL, characteristic of three subtypes of childhood leukaemia, was investigated in the preterm and full term infant samples using a nested reverse transcriptase polymerase chain reaction method. Serial pre- and post-x ray samples from 42 preterm babies, pre-x ray samples from an additional 46 preterm infants, and cord blood samples from 100 normal full term infants were screened for fusion gene transcripts. RESULTS: No leukaemic fusion gene transcripts were detected in preterm infants following exposure to diagnostic x rays. A BCR-ABL transcript was identified in a single preterm infant prior to x ray exposure. TEL-AML1 transcripts were detected in cord blood samples from two full term infants. MLL-AF4 transcripts were not detected in any of the pre- or full term infants tested. CONCLUSIONS: Exposure of the preterm infants to x rays in this small series and at the doses used for diagnostic purposes did not induce leukaemic fusion gene expression, but we cannot exclude the possibility that a small proportion of preterm infants may be unusually sensitive to x rays.


Subject(s)
Fusion Proteins, bcr-abl/blood , Infant, Premature/blood , Oncogene Proteins, Fusion/blood , Prenatal Diagnosis/adverse effects , X-Rays/adverse effects , Cell Line , Core Binding Factor Alpha 2 Subunit , Female , Gene Amplification , Humans , Infant, Newborn , Leukemia/etiology , Male , Myeloid-Lymphoid Leukemia Protein , RNA/analysis , Radiometry , Reverse Transcriptase Polymerase Chain Reaction/methods
17.
Am J Phys Anthropol ; 119(1): 27-36, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12209571

ABSTRACT

Seven human skeletons from a large assemblage from a rural English Medieval burial site show lesions, predominantly proliferative in nature, on the visceral surfaces of the ribs. In order to investigate whether these rib lesions were regularly associated with tuberculous infection, these individuals, together with a group of age- and sex-matched control skeletons without bony signs of infection, were subjected to polymerase chain reaction (PCR) assays aimed at detecting traces of DNA from infecting microorganisms of the Mycobacterium tuberculosis complex. The results provided no evidence for any regular association between visceral surface rib lesions and the presence of M. tuberculosis complex DNA in the study group. The significance of these findings for the paleopathological interpretation of visceral surface rib lesions is discussed.


Subject(s)
DNA, Bacterial/genetics , Mycobacterium tuberculosis/genetics , Ribs/pathology , Tuberculosis, Pulmonary/history , Adolescent , Adult , Child , England , Female , History, Medieval , Humans , Male , Middle Aged , Paleopathology , Polymerase Chain Reaction , Tuberculosis, Pulmonary/microbiology
18.
Ann Oncol ; 13 Suppl 1: 30-3, 2002.
Article in English | MEDLINE | ID: mdl-12078899

ABSTRACT

Although the occurrence of familial Hodgkin's lymphoma (HL) is a rare event, genetic susceptibility as a cause of HL and its influence on treatment outcome may not be rare. However, results obtained from the analysis of HL families will probably have broad implications with regard to understanding common pathogenic factors leading to the development of the disease. The description of anticipation among the affected offspring of HL patients further strengthens the view that heritable factors contribute to development of HL. Moreover, the finding that particular human leukocyte antigen (HLA) alleles are associated with susceptibility to HL may be regarded as a hint to the presence of an as yet undefined infectious agent, leading to the growth of a malignant lymphoma cell clone in those patients that are more susceptible to this agent due to their HLA genotype. In addition, since an intrinsic genomic instability was observed in a proportion of HL patients, it is plausible that these patients are not only susceptible to the causation of HL, but are also at a higher risk of developing therapy-related (TR) secondary cancers following treatment. Estimation of sister chromatid exchange was established as a tool to identify patients at higher risk of TR cancer. In this context the use of therapeutic agents known to increase genomic instability should be carefully considered prior to determing the best treatment. The future identification of heritable factors contributing to HL will be of importance both with regard to diagnosis as well as treatment of HL patients.


Subject(s)
Genetic Predisposition to Disease , Hodgkin Disease/genetics , Age of Onset , Genotype , HLA Antigens/metabolism , Humans , Neoplasms, Second Primary/genetics , Risk Factors , Sister Chromatid Exchange/genetics
19.
Br J Cancer ; 86(7): 1070-7, 2002 Apr 08.
Article in English | MEDLINE | ID: mdl-11953851

ABSTRACT

To investigate whether infections or other environmental exposures may be involved in the aetiology of childhood central nervous system tumours, we have analysed for space-time clustering and seasonality using population-based data from the North West of England for the period 1954 to 1998. Knox tests for space-time interactions between cases were applied with fixed thresholds of close in space, <5 km, and close in time, <1 year apart. Addresses at birth and diagnosis were used. Tests were repeated replacing geographical distance with distance to the Nth nearest neighbour. N was chosen such that the mean distance was 5 km. Data were also examined by a second order procedure based on K-functions. Tests for heterogeneity and Edwards' test for sinusoidal variation were applied to examine changes of incidence with month of birth or diagnosis. There was strong evidence of space-time clustering, particularly involving cases of astrocytoma and ependymoma. Analyses of seasonal variation showed excesses of cases born in the late Autumn or Winter. Results are consistent with a role for infections in a proportion of cases from these diagnostic groups. Further studies are needed to identify putative infectious agents.


Subject(s)
Astrocytoma/etiology , Brain Neoplasms/etiology , Ependymoma/etiology , Infections/complications , Adolescent , Astrocytoma/epidemiology , Astrocytoma/microbiology , Birth Certificates , Brain Neoplasms/epidemiology , Brain Neoplasms/microbiology , Child , Child, Preschool , Ependymoma/epidemiology , Ependymoma/microbiology , Female , Geography , Humans , Incidence , Infant , Infant, Newborn , Male , Seasons
20.
Arch Dis Child Fetal Neonatal Ed ; 86(2): F96-F101, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11882551

ABSTRACT

AIMS: To investigate whether antenatal steroids reduce the incidence of cerebral white matter lesions in very low birthweight infants. METHODS: A total of 224 newborn infants of < 31 weeks gestational age and weighing < 1500 g was studied between January 1998 and June 2000. Obstetric and neonatal information was obtained from the case notes. The study population was subdivided into two groups according to antenatal steroid exposure. A complete course of treatment consisted of two doses of 12 mg each of betamethasone given at an interval of 12-24 hours. Infants in group 1 were born to mothers who had not received betamethasone, or were delivered within 24 hours of receiving the first dose of steroid. Infants in group 2 were born to mothers who had received one or more complete courses of betamethasone and were delivered > 24 hours after receiving the first dose of steroid. RESULTS: The two groups contained statistically similar proportions of boys and girls, and the infants had similar birth weights and survival rates. Those in group 2, compared with those in group 1, had a lower gestational age (p = 0.02) and a lower incidence of white matter lesions on cranial ultrasound scans (p = 0.03). Stepwise logistic regression analysis showed that gestational age (p = 0.0002) and a complete course of antenatal steroids (p = 0.02) had independent effects on cerebral white matter lesions. CONCLUSIONS: These observations suggest that a complete course of antenatal steroids may have a protective effect against cerebral white matter lesions in very low birthweight infants.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Betamethasone/therapeutic use , Brain Diseases/prevention & control , Glucocorticoids/therapeutic use , Infant, Premature, Diseases/prevention & control , Prenatal Care/methods , Analysis of Variance , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature , Infant, Very Low Birth Weight , Logistic Models , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...